Nektar Therapeutics News, Nektar Therapeutics Quote, NKTR Quote

Nektar Therapeutics (NQ:NKTR) Delayed: 38.27 -0.95 (2.42%)

Prev. Close

$39.22

Today 6M 1Y 5Y

Open

$39.09

52 Wk High

$19.98

52 Wk Low

$10.52

Day High

$40.35

Day Low

$38.25

P/E

N/A

EPS

$-1.45

Volume

619,432

Friends, Peers and Foes (?): LLY, ABBV, BSX, EOSE, SLNO (more...)

ALERTS | RSS

Oct 20, 2026 06:01 AM Form S-8 NEKTAR THERAPEUTICS
Oct 12, 2026 06:12 AM Leerink Starts Nektar Therapeutics (NKTR) at Outperform
Oct 12, 2026 02:21 AM UBS Starts Nektar Therapeutics (NKTR) at Neutral
Oct 8, 2026 04:05 PM Raymond James Starts Nektar Therapeutics (NKTR) at Market Perform
Oct 5, 2026 06:57 AM Citi reiterates buy rating on Nektar Therapeutics with $151 target
Oct 2, 2026 06:56 AM H.C. Wainwright Reiterates Buy Rating on Nektar Therapeutics (NKTR)
Oct 1, 2026 07:58 AM Form 8-K NEKTAR THERAPEUTICS For: Oct 01
Oct 1, 2026 07:34 AM Nektar drug shows durability in skin disease trials at EADV 2026
Oct 1, 2026 07:30 AM New Rezpegaldesleukin Data Supporting Long-term Durability and Disease Improvement in Patients with Alopecia Areata and Atopic Dermatitis at EADV Congress 2026
Sep 30, 2026 10:31 AM Nektar presents early biomarker data for eczema drug at EADV 2026

Entities mentioned with NKTR

View All Entities